- Home
- BCAB vs KXIN Comparison
BCAB vs KXIN Comparison
Compare BCAB & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | KXIN |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | China |
| Employees | N/A | 13 |
| Industry | Medicinal Chemicals and Botanical Products | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 7.0M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCAB | KXIN |
|---|---|---|
| Price | $3.39 | $5.50 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 44.0K | ★ 60.5K |
| Earning Date | 05-08-2026 | 11-26-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.11 |
| 52 Week High | $6.52 | $22.00 |
Technical Indicators
Market Signals| Indicator | BCAB | KXIN |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 54.59 |
| Support Level | $3.31 | $5.30 |
| Resistance Level | $4.24 | $6.11 |
| Average True Range (ATR) | 0.30 | 0.55 |
| MACD | -0.07 | 0.05 |
| Stochastic Oscillator | 24.26 | 60.89 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs. The company's operations are organized on a single reportable segment, which includes all activities related to the discovery, development, and commercialization of its CAB products.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.